Breaking News Instant updates and real-time market news.

DIS

Disney

$124.97 /

+0.01 (+0.01%)

16:17
10/12/20
10/12
16:17
10/12/20
16:17

Disney reorganizes businesses with more focus on DTC strategy

Disney announced a strategic reorganization of its media and entertainment businesses. Under the new structure, Disney's creative engines will focus on developing and producing original content for the company's streaming services, as well as for legacy platforms, while distribution and commercialization activities will be centralized into a single, global Media and Entertainment Distribution organization. The new Media and Entertainment Distribution group will be responsible for all monetization of content-both distribution and ad sales-and will oversee operations of the company's streaming services. It will also have sole P&L accountability for Disney's media and entertainment businesses. The creation of content will be managed in three distinct groups-Studios, General Entertainment, and Sports-headed by current leaders Alan F. Horn and Alan Bergman, Peter Rice, and James Pitaro. The Media and Entertainment Distribution group will be headed by Kareem Daniel, formerly President, Consumer Products, Games and Publishing. All five leaders will report directly to Bob Chapek, Chief Executive Officer, The Walt Disney Company. Disney Parks, Experiences and Products will continue to operate under its existing structure, led by Josh D'Amaro, Chairman, Disney Parks, Experiences and Products, who continues to report to Mr. Chapek. Rebecca Campbell will serve as Chairman, International Operations and Direct-to-Consumer. Bob Iger, in his role as Executive Chairman, will continue to direct the company's creative endeavors. Under the new structure, the Company's three content groups will be responsible and accountable for producing and delivering content for theatrical, linear and streaming, with the primary focus being the Company's streaming services. Horn and Bergman will serve as Chairmen, Studios Content, which will focus on creating branded theatrical and episodic content based on the company's powerhouse franchises for theatrical exhibition, Disney+ and the company's other streaming services. The group will include the content engines of The Walt Disney Studios, including Disney live action and Walt Disney Animation Studios, Pixar Animation Studios, Marvel Studios, Lucasfilm, 20th Century Studios and Searchlight Pictures. Rice will serve as Chairman, General Entertainment Content, which will focus on creating general entertainment episodic and original long-form content for the Company's streaming platforms and its cable and broadcast networks. The group will include the content engines of 20th Television, ABC Signature and Touchstone Television; ABC News; Disney Channels; Freeform; FX; and National Geographic. Pitaro will serve as Chairman, ESPN and Sports Content, which will focus on ESPN's live sports programming, as well as sports news and original and non-scripted sports-related content, for the cable channels, ESPN+, and ABC. With the reorganization, the Direct-to-Consumer and International business will no longer be managed on a combined basis. In Ms. Campbell's role leading international operations, she will be responsible for coordinating and integrating activities across the various business units in each market to best represent the Company's overall interests, and will report to Mr. Chapek. In her role leading direct-to-consumer operations for Disney+, Hulu and ESPN+, she will report to Mr. Daniel. The new structure is effective immediately, and the Company expects to transition to financial reporting under this structure in the first quarter of fiscal 2021.

  • 12

    Nov

DIS Disney
$124.97 /

+0.01 (+0.01%)

10/06/20 Piper Sandler
Netflix remains top video platform among teens, says Piper Sandler
10/02/20 JPMorgan
Disney price target raised to $155 from $135 at JPMorgan
10/01/20 MoffettNathanson
Disney price target raised to $136 from $118 at MoffettNathanson
10/01/20 Citi
Disney layoffs represent 13% of total employee base, says Citi

TODAY'S FREE FLY STORIES

Conference/Events
Eaton to host virtual investor day » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
ETN

Eaton

$130.11 /

-2.64 (-1.99%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETN Eaton
$130.11 /

-2.64 (-1.99%)

ETN Eaton
$130.11 /

-2.64 (-1.99%)

02/16/21
Eaton participates in a conference call with Wolfe Research
02/16/21
Fly Intel: Top five analyst upgrades
02/16/21 HSBC
Eaton upgraded to Buy from Hold at HSBC
02/16/21 HSBC
Eaton upgraded to Buy from Hold at HSBC
ETN Eaton
$130.11 /

-2.64 (-1.99%)

ETN Eaton
$130.11 /

-2.64 (-1.99%)

Earnings
1Life Healthcare reports Q4 EPS (6c), consensus (14c) » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
ONEM

1Life Healthcare

$48.69 /

-3.24 (-6.24%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

02/04/21 Citi
1Life Healthcare price target raised to $62 from $42 at Citi
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/29/21 SVB Leerink
1Life Healthcare upgraded to Outperform from Market Perform at SVB Leerink
01/20/21 William Blair
1Life Healthcare jumps after William Blair sees vaccine rollout benefits
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

ONEM 1Life Healthcare
$48.69 /

-3.24 (-6.24%)

Earnings
EOG Resources reports Q4 adjusted EPS 71c, consensus 35c » 17:15
02/25/21
02/25
17:15
02/25/21
17:15
EOG

EOG Resources

$70.60 /

-1.79 (-2.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

02/02/21 Barclays
EOG Resources price target lowered to $60 from $67 at Barclays
01/22/21 Piper Sandler
EOG Resources price target raised to $70 from $60 at Piper Sandler
01/14/21 Barclays
EOG Resources downgraded to Equal Weight from Overweight at Barclays
01/11/21 Mizuho
EOG Resources price target raised to $88 from $71 at Mizuho
EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

EOG EOG Resources
$70.60 /

-1.79 (-2.47%)

Syndicate
Edesa Biotech announces $3.5M bought deal offering of common shares » 17:14
02/25/21
02/25
17:14
02/25/21
17:14
EDSA

Edesa Biotech

$6.60 /

+0.2 (+3.13%)

Edesa Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

EDSA Edesa Biotech
$6.60 /

+0.2 (+3.13%)

03/30/20 Brookline
Edesa Biotech initiated with a Buy at Brookline
Earnings
Vicor reports Q4 EPS 25c, consensus 17c » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
VICR

Vicor

$90.00 /

-5.23 (-5.49%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VICR Vicor
$90.00 /

-5.23 (-5.49%)

VICR Vicor
$90.00 /

-5.23 (-5.49%)

12/30/20 Needham
Needham names Applied Materials top pick in 2021, boosts price target to $110
10/23/20 Needham
Vicor price target raised to $95 from $85 at Needham
09/18/20 Northland
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland
07/24/20 BWS Financial
Vicor price target raised to $100 from $84 at BWS Financial
VICR Vicor
$90.00 /

-5.23 (-5.49%)

  • 11
    Jun
Earnings
Mirati Therapeutics reports Q4 EPS ($2.08), consensus (2.23) » 17:13
02/25/21
02/25
17:13
02/25/21
17:13
MRTX

Mirati Therapeutics

$195.44 /

-6.96 (-3.44%)

Reports Q4 revenue $1.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

01/15/21 H.C. Wainwright
Mirati Therapeutics price target lowered to $257 from $265 at H.C. Wainwright
12/08/20 JMP Securities
Mirati Therapeutics initiated with a Market Perform at JMP Securities
11/17/20 BofA
Mirati Therapeutics downgraded to Underperform from Neutral at BofA
11/10/20 Guggenheim
Mirati Therapeutics downgraded to Neutral from Buy at Guggenheim
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

  • 28
    Oct
MRTX Mirati Therapeutics
$195.44 /

-6.96 (-3.44%)

Syndicate
AvalonBay files automatic mixed securities shelf  17:12
02/25/21
02/25
17:12
02/25/21
17:12
AVB

AvalonBay

$180.39 /

-4.67 (-2.52%)

 
ShowHide Related Items >><<
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

02/22/21 KeyBanc
AvalonBay upgraded to Overweight at KeyBanc on coastal recovery
02/21/21 KeyBanc
AvalonBay upgraded to Overweight from Sector Weight at KeyBanc
02/09/21 BofA
Camden Property downgraded to Neutral from Buy at BofA
12/21/20 JPMorgan
JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021
AVB AvalonBay
$180.39 /

-4.67 (-2.52%)

Conference/Events
Viatris to host virtual investor day » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
VTRS

Viatris

$15.05 /

-0.245 (-1.60%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

VTRS Viatris
$15.05 /

-0.245 (-1.60%)

02/23/21 Barclays
Viatris price target lowered to $20 from $26 at Barclays
01/06/21 RBC Capital
Viatris named one of top stocks to own in 2021 by RBC Capital
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/14/20 Bernstein
Viatris initiated with a Market Perform at Bernstein
VTRS Viatris
$15.05 /

-0.245 (-1.60%)

VTRS Viatris
$15.05 /

-0.245 (-1.60%)

Hot Stocks
Beyond Meat says 'not prepared to elaborate' on new partnerships » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
BYND

Beyond Meat

$143.89 /

-8.21 (-5.40%)

Says plans to hold…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

02/03/21
Fly Intel: Top five analyst downgrades
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
02/03/21 DA Davidson
Beyond Meat downgraded to Underperform from Neutral at DA Davidson
01/27/21 Canaccord
Beyond Meat price target raised to $170 from $125 at Canaccord
BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

BYND Beyond Meat
$143.89 /

-8.21 (-5.40%)

Earnings
AnaptysBio reports Q4 EPS $1.20, consensus $1.39 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ANAB

AnaptysBio

$26.00 /

-0.39 (-1.48%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

02/11/21 JPMorgan
JPMorgan double upgrades AnaptysBio, more than doubles price target
02/11/21 JPMorgan
AnaptysBio upgraded to Overweight from Underweight at JPMorgan
10/27/20
Fly Intel: Top five analyst upgrades
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

ANAB AnaptysBio
$26.00 /

-0.39 (-1.48%)

Earnings
Erie Indemnity reports Q4 EPS $1.20 , consensus $1.21 » 17:11
02/25/21
02/25
17:11
02/25/21
17:11
ERIE

Erie Indemnity

$243.85 /

-4.15 (-1.67%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

ERIE Erie Indemnity
$243.85 /

-4.15 (-1.67%)

Earnings
Nektar reports Q4 EPS (65c), consensus (68c) » 17:09
02/25/21
02/25
17:09
02/25/21
17:09
NKTR

Nektar

$22.47 /

-0.29 (-1.27%)

Reports Q4 revenue $23.5…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

NKTR Nektar
$22.47 /

-0.29 (-1.27%)

02/22/21 Benchmark
Nektar downgraded to Hold on valuation at Benchmark
02/22/21 Benchmark
Nektar downgraded to Hold from Buy at Benchmark
02/17/21 William Blair
William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ
02/17/21 Piper Sandler
Nektar collaborations could create $500M-$800M opportunity, says Piper Sandler
NKTR Nektar
$22.47 /

-0.29 (-1.27%)

Earnings
Codexis sees FY21 revenue $82M-$85M, consensus $80.53M » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Sees FY21 adjusted gross…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

Earnings
Assembly Biosciences reports Q4 EPS ($1.75), consensus (90c) » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
ASMB

Assembly Biosciences

$5.53 /

-0.13 (-2.30%)

"Our strategy for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

12/04/20 Mizuho
Assembly Biosciences price target lowered to $13 from $30 at Mizuho
11/06/20 Jefferies
Assembly Biosciences downgraded to Hold from Buy at Jefferies
10/19/20 Truist
Assembly Biosciences initiated with a Buy at Truist
07/21/20 Baird
Assembly Biosciences HBV deal a positive, says Baird
ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

ASMB Assembly Biosciences
$5.53 /

-0.13 (-2.30%)

Earnings
Pembina Pipeline reports Q4 EPS ($2.28), may not compare to consensus 44c » 17:08
02/25/21
02/25
17:08
02/25/21
17:08
PBA

Pembina Pipeline

$27.50 /

-0.645 (-2.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

PBA Pembina Pipeline
$27.50 /

-0.645 (-2.29%)

02/09/21 Scotiabank
Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank
01/27/21 Credit Suisse
Pembina Pipeline price target raised to C$42 from C$40 at Credit Suisse
01/27/21 National Bank
Pembina Pipeline price target raised to C$38 from C$36 at National Bank
01/22/21 Stifel
Pembina Pipeline price target raised to C$37 from C$34 at Stifel
Earnings
Ranger Energy reports Q4 EPS (43c), consensus (31c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
RNGR

Ranger Energy

$5.54 /

+0.09 (+1.65%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

01/04/21 Evercore ISI
Ranger Energy upgraded to Outperform from In Line at Evercore ISI
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy on valuation at B. Riley Securities
12/10/20 B. Riley Securities
Ranger Energy upgraded to Buy from Neutral at B. Riley Securities
04/15/20 Piper Sandler
Ranger Energy downgraded to Neutral from Overweight at Piper Sandler
RNGR Ranger Energy
$5.54 /

+0.09 (+1.65%)

Earnings
Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
FLY

Fly Leasing

$12.42 /

-0.19 (-1.51%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

01/26/21 Cowen
Fly Leasing price target raised to $13 from $9 at Cowen
01/25/21 Deutsche Bank
Fly Leasing price target raised to $11 from $8.50 at Deutsche Bank
11/16/20 Deutsche Bank
Fly Leasing price target lowered to $8.50 from $10 at Deutsche Bank
05/26/20 JPMorgan
JPMorgan upgrades Fly Leasing with stock rally lagging peers
FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

FLY Fly Leasing
$12.42 /

-0.19 (-1.51%)

Earnings
Codexis reports Q4 EPS (6c), consensus (12c) » 17:06
02/25/21
02/25
17:06
02/25/21
17:06
CDXS

Codexis

$21.23 /

-1.67 (-7.29%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

CDXS Codexis
$21.23 /

-1.67 (-7.29%)

12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

  • 03
    Dec
CDXS Codexis
$21.23 /

-1.67 (-7.29%)

Hot Stocks
Southwest Gas sees FY21 CapEx approximately $700M  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
Southwest Gas sees FY21 EPS $3.95-$4.20, consensus $4.18  17:05
02/25/21
02/25
17:05
02/25/21
17:05
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

 
ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
Southwest Gas reports Q4 EPS $1.82, consensus $1.61 » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
SWX

Southwest Gas

$64.17 /

-0.955 (-1.47%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

01/29/21
Fly Intel: Top five analyst downgrades
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral on regulatory risk at JPMorgan
01/29/21 JPMorgan
Southwest Gas downgraded to Neutral from Overweight at JPMorgan
12/10/20 BofA
Southwest Gas cut to Underperform at BofA after AZ rate case decision
SWX Southwest Gas
$64.17 /

-0.955 (-1.47%)

Earnings
PetIQ reports Q4 EPS (41c), consensus (10c) » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
PETQ

PetIQ

$37.25 /

+1.77 (+4.99%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

10/15/20 Jefferies
PetIQ assumed with a Buy at Jefferies
08/17/20 Guggenheim
Zoetis price target raised to $175 from $139 at Guggenheim
07/01/20 Raymond James
PetIQ price target raised to $41 from $35 at Raymond James
06/25/20 Guggenheim
PetIQ price target raised to $44 from $33.50 at Guggenheim
PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

PETQ PetIQ
$37.25 /

+1.77 (+4.99%)

Hot Stocks
Sallie Mae increases price range, extends expiration to buy up to $1B in stock » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
SLM

Sallie Mae

$14.99 /

-0.23 (-1.51%)

Sallie Mae announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

01/29/21 Barclays
Sallie Mae price target raised to $18 from $15 at Barclays
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
01/29/21 Citi
Sallie Mae price target raised to $16 from $12 at Citi
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

SLM Sallie Mae
$14.99 /

-0.23 (-1.51%)

Earnings
Cardiff Oncology reports Q4 EPS (19c), consensus (14c) » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
CRDF

Cardiff Oncology

$9.78 /

-0.52 (-5.05%)

Reports Q4 revenue $119K,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

02/11/21 Piper Sandler
Piper says Cardiff Oncology mCRPC opportunity 'more interesting' after data
10/22/20
Fly Intel: Top five analyst initiations
10/22/20 H.C. Wainwright
Cardiff Oncology initiated with a Buy at H.C. Wainwright
10/21/20 Maxim
Cardiff Oncology price target raised to $20 from $14 at Maxim
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

  • 30
    Sep
CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

CRDF Cardiff Oncology
$9.78 /

-0.52 (-5.05%)

Hot Stocks
Vivint Smart Home sues ADT for patent infringement » 17:04
02/25/21
02/25
17:04
02/25/21
17:04
VVNT

Vivint Smart Home

$17.37 /

-2.02 (-10.42%)

, ADT

ADT Inc.

$9.48 /

-0.77 (-7.51%)

Vivint Smart Home (VVNT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

07:11 Today Deutsche Bank
Vivint Smart Home price target lowered to $21 from $24 at Deutsche Bank
01/15/21 Deutsche Bank
Vivint Smart Home downgraded to Hold on valuation at Deutsche Bank
01/15/21 Deutsche Bank
Vivint Smart Home downgraded to Hold from Buy at Deutsche Bank
11/05/20 JPMorgan
Vivint Smart Home price target raised to $34 from $30 at JPMorgan
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/29/21 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
01/15/21 Deutsche Bank
ADT Inc. assumed with a Hold at Deutsche Bank
11/06/20 Roth Capital
Alarm.com price target raised to $75 from $65 at Roth Capital
VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

  • 16
    Sep
ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

VVNT Vivint Smart Home
$17.37 /

-2.02 (-10.42%)

ADT ADT Inc.
$9.48 /

-0.77 (-7.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.